DMK Pharmaceuticals Corporation
DMKPQ · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $2,569 | $8,855 | $3,823 | $3,751 |
| - Cash | $1,081 | $23,251 | $6,749 | $8,811 |
| + Debt | $343 | $692 | $4,210 | $4,079 |
| Enterprise Value | $1,830 | -$13,703 | $1,284 | -$981 |
| Revenue | $4,756 | $2,209 | $2,777 | $22,114 |
| % Growth | 115.3% | -20.5% | -87.4% | – |
| Gross Profit | -$2,898 | -$4,663 | -$3,550 | $6,435 |
| % Margin | -60.9% | -211.1% | -127.9% | 29.1% |
| EBITDA | -$23,575 | -$30,634 | -$33,506 | -$25,070 |
| % Margin | -495.7% | -1,387% | -1,206.7% | -113.4% |
| Net Income | -$26,478 | -$45,828 | -$49,391 | -$27,513 |
| % Margin | -556.7% | -2,074.9% | -1,778.8% | -124.4% |
| EPS Diluted | -12.37 | -22.25 | -44.57 | -36.16 |
| % Growth | 44.4% | 50.1% | -23.3% | – |
| Operating Cash Flow | -$25,901 | -$37,785 | -$20,901 | -$19,886 |
| Capital Expenditures | -$680 | -$1,223 | -$700 | -$2,866 |
| Free Cash Flow | -$26,581 | -$39,009 | -$21,602 | -$22,752 |